NYSE:WAT - Waters Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $235.41 +0.83 (+0.35 %) (As of 02/22/2019 04:00 PM ET)Previous Close$235.41Today's Range$234.26 - $236.3052-Week Range$167.93 - $236.30Volume330,119 shsAverage Volume588,354 shsMarket Capitalization$17.83 billionP/E Ratio28.40Dividend YieldN/ABeta1.17 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. The company also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. In addition, the company offers thermal analysis, rheometry, and calorimetry instruments, which are used in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for use in various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts. Receive WAT News and Ratings via Email Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services SectorComputer and Technology Current SymbolNYSE:WAT Previous Symbol CUSIP94184810 CIK1000697 Webwww.waters.com Phone508-478-2000Debt Debt-to-Equity Ratio0.61 Current Ratio2.26 Quick Ratio2.01Price-To-Earnings Trailing P/E Ratio28.40 Forward P/E Ratio25.18 P/E Growth2.32 Sales & Book Value Annual Sales$2.42 billion Price / Sales7.37 Cash Flow$9.9666 per share Price / Cash Flow23.62 Book Value$20.69 per share Price / Book11.38Profitability EPS (Most Recent Fiscal Year)$8.29 Net Income$593.79 million Net Margins24.54% Return on Equity34.18% Return on Assets15.69%Miscellaneous Employees7,000 Outstanding Shares75,750,000Market Cap$17.83 billion Next Earnings Date4/23/2019 (Estimated) OptionableOptionable Waters (NYSE:WAT) Frequently Asked Questions What is Waters' stock symbol? Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT." How will Waters' stock buyback program work? Waters announced that its board has initiated a share repurchase plan on Tuesday, April 24th 2018, which authorizes the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 18.2% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board believes its shares are undervalued. How were Waters' earnings last quarter? Waters Co. (NYSE:WAT) announced its quarterly earnings results on Wednesday, January, 23rd. The medical instruments supplier reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.64 by $0.23. The medical instruments supplier earned $715 million during the quarter, compared to the consensus estimate of $702.74 million. Waters had a return on equity of 34.18% and a net margin of 24.54%. Waters's revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.51 earnings per share. View Waters' Earnings History. When is Waters' next earnings date? Waters is scheduled to release their next quarterly earnings announcement on Tuesday, April 23rd 2019. View Earnings Estimates for Waters. What guidance has Waters issued on next quarter's earnings? Waters updated its FY19 earnings guidance on Wednesday, January, 23rd. The company provided earnings per share guidance of $9.20-9.45 for the period, compared to the Thomson Reuters consensus estimate of $9.18. Waters also updated its FY 2019 guidance to $9.20-9.45 EPS. What price target have analysts set for WAT? 14 brokers have issued 12 month price objectives for Waters' stock. Their predictions range from $177.00 to $260.00. On average, they anticipate Waters' stock price to reach $205.3715 in the next year. This suggests that the stock has a possible downside of 12.8%. View Analyst Price Targets for Waters. What is the consensus analysts' recommendation for Waters? 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 2 sell ratings, 11 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters. Has Waters been receiving favorable news coverage? News stories about WAT stock have trended neutral recently, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Waters earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. Who are some of Waters' key competitors? Some companies that are related to Waters include Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO). What other stocks do shareholders of Waters own? Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Home Depot (HD), Cisco Systems (CSCO), Walmart (WMT), Raytheon (RTN), Mcdonald's (MCD), Honeywell International (HON), Starbucks (SBUX) and Philip Morris International (PM). Who are Waters' key executives? Waters' management team includes the folowing people: Mr. Christopher James O'Connell, Chairman & CEO (Age 52)Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)Dr. Michael C. Harrington, Sr. VP of Global Markets (Age 58)Mr. Ian S. King, Sr. VP of Global Products (Age 62)Mr. Eugene G. Cassis, Sr. Advisor (Age 62) Who are Waters' major shareholders? Waters' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.36%), Fundsmith LLP (6.51%), Massachusetts Financial Services Co. MA (6.42%), Bank of New York Mellon Corp (5.83%), Baillie Gifford & Co. (3.32%) and Jensen Investment Management Inc. (1.39%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters. Which institutional investors are selling Waters stock? WAT stock was sold by a variety of institutional investors in the last quarter, including Nomura Asset Management Co. Ltd., Ownership Capital B.V., Bank of New York Mellon Corp, D. E. Shaw & Co. Inc., Fundsmith LLP, Bessemer Group Inc., Mackenzie Financial Corp and Principal Financial Group Inc.. Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Joann A Reed, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters. Which institutional investors are buying Waters stock? WAT stock was bought by a variety of institutional investors in the last quarter, including Bristol John W & Co. Inc. NY, Massachusetts Financial Services Co. MA, Nordea Investment Management AB, Citigroup Inc., Geode Capital Management LLC, Dimensional Fund Advisors LP, Duality Advisers LP and Caledonia Investments PLC. View Insider Buying and Selling for Waters. How do I buy shares of Waters? Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Waters' stock price today? One share of WAT stock can currently be purchased for approximately $235.41. How big of a company is Waters? Waters has a market capitalization of $17.83 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,000 workers across the globe. What is Waters' official website? The official website for Waters is http://www.waters.com. How can I contact Waters? Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected] MarketBeat Community Rating for Waters (NYSE WAT)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 355 (Vote Outperform)Underperform Votes: 472 (Vote Underperform)Total Votes: 827MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2019 by MarketBeat.com StaffFeatured Article: Should You Consider an Index Fund?